Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Dividend aristocrats are companies that consistently increase their dividends for many years. Understanding them can improve your investment decisions.
4,951 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
A high-yield ETF draws retiree interest, but Warren Buffett would never chase yields at the expense of long-term grow...
Investors chase value, momentum and income as markets wobble in July 2026. This report breaks down the retirement por...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Investing in mobile infrastructure requires understanding the earnings engine behind 5G networks. This guide breaks d...
Gold prices lure investors to miners as a way to gain leveraged exposure to gold. This article compares two different...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
Retirees face rising costs and market surprises. This guide explains why building several income streams matters in 2...
Deciding between SOXX and IYW means choosing between a laser focus on chips and a wide tech umbrella. This guide brea...
Three energy ETFs yielding above 2.5% are delivering 24% to 31% returns in 2026, pairing income with notable capital ...
Oracle posted a strong quarter with a beat and raise, but the stock traded lower after earnings. This piece breaks do...